Clinical Perspectives on Patient Care


Course Fees

*Discounted fee based upon purchase of vacation package. If purchased separately, please add $400 to the above fees.


Join us for 12 hours of COPE-approved CE.  This program will reach the cutting edge of contemporary medical management with topical and oral drugs used to treat eye disease, including glaucoma. The clinical application of oral pharmaceuticals will be stressed with case presentations. Emphasis will be given to sharpening the clinician’s skills in diagnosing and medically managing a variety of ocular disease entities.  Diagnostic and therapeutic pearls will be shared during the case discussions.

Therapeutic Update 

Session 1 – Current Trends in Medical Management 

Session 2 – Therapeutic Strategies in Clinical Eye Care


Comprehensive Glaucoma Update

Session 3 – Contemporary Glaucoma Care

Session 4 – Reducing the Pressure in Glaucoma Decision Making


Clinical Grand Rounds 

Session 5 – Clinical Grand Rounds

Session 6 – On Call with Melton -Thomas

Course Content

Learning Objectives



Dr. Ron Melton has lectured nationally and internationally at over 1,000 continuing medical education meetings with the goal of educating optometrists around the world about ocular disease. He was recognized as one of the top 150 optometrists in the U.S. by Newsweek’s “America’s Best Optometrists Award” in 2021 and 2022.  He was honored as a co-recipient of the “Pioneer in Optometry” recognition by the Editorial Board of Primary Care Optometry News in April 2015 for contributions in optometry education.   Dr. Melton was named co-recipient of the American Academy of Optometry 2014 Vincent Ellerbrock Clinician Educator Award for outstanding and sustained contributions to the Academy’s Lectures and Workshops program.  He sits on the editorial advisory board of Review of Optometry.  Dr. Melton has authored or co-authored over 100 papers on optometry and is the co-author of the popular annual “Clinical Guide to Ophthalmic Drugs” for Review of Optometry”, now in its twenty-seventh year.  Dr. Melton has acted as an investigator in more than 50 clinical research trials.  Currently, he is a member of the adjunct faculty at Salus University (Pennsylvania College of Optometry) and Indiana University (School of Optometry).   He is certified as a Diplomate with the American Board of Optometry.  He is in a group practice in Charlotte, North Carolina, where he has staff privileges at Novant Health Presbyterian Medical Center. 


Scroll to Top